CCND1 and ductal breast carcinoma in situ: Similarly there was no significant difference in the amplification frequencies of HER2, C-MYC, CCND1 and FGFR1 in pure DCIS and DCIS associated with invasive carcinomas (Table 2 and Figure 2).